FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER
Patients with end-stage renal disease (ESRD) often experience secondary bone and mineral disorder requiring treatment with phosphate-binder (PB) medications, vitamin D sterols, and calcimimetics. Ferric citrate is an oral, iron-based PB in clinical development that has been shown to reduce serum pho...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Society of Nephrology
2012-06-01
|
| Series: | Kidney Research and Clinical Practice |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211913212004470 |